NuGen Medical Devices Inc.

TSXV:NGMD Stock Report

Market Cap: CA$17.4m

NuGen Medical Devices Management

Management criteria checks 1/4

NuGen Medical Devices' CEO is Karen Dunlap, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is CA$142.80K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.069% of the company’s shares, worth CA$12.00K. The average tenure of the management team and the board of directors is 1.3 years and 1.9 years respectively.

Key information

Karen Dunlap

Chief executive officer

CA$142.8k

Total compensation

CEO salary percentage100.0%
CEO tenureless than a year
CEO ownership0.07%
Management average tenure1.3yrs
Board average tenure1.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Karen Dunlap's remuneration changed compared to NuGen Medical Devices's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$8m

Jun 30 2024n/an/a

-CA$8m

Mar 31 2024n/an/a

-CA$9m

Dec 31 2023CA$143kCA$143k

-CA$9m

Sep 30 2023n/an/a

-CA$9m

Jun 30 2023n/an/a

-CA$7m

Mar 31 2023n/an/a

-CA$6m

Dec 31 2022CA$11kCA$11k

-CA$6m

Compensation vs Market: Karen's total compensation ($USD99.37K) is below average for companies of similar size in the Canadian market ($USD164.07K).

Compensation vs Earnings: Karen's compensation has increased whilst the company is unprofitable.

CEO

Karen Dunlap (77 yo)

less than a year

Tenure

CA$142,800

Compensation

Ms. Karen Dunlap was Interim Chief Customer Officer & Director of NuGen Medical Devices Inc. from December 15, 2022 to 2024. Ms. Dunlap was Independent Director of NuGen Medical Devices Inc. from 2019 to D...

Leadership Team

NamePositionTenureCompensationOwnership
Karen Dunlap
Chief Executive Officerless than a yearCA$142.80k0.069%
CA$ 12.0k
Veronique Laberge
CFO & Secretary1.8yrsCA$183.00k0.34%
CA$ 60.0k
Nicky Canton
Executive VP & COOno dataCA$211.97k0.046%
CA$ 8.0k
Lin Liang
Executive Chairmanless than a yearno datano data
Elisha Dillon
Head of Global Sales & Strategic Partnerships3.1yrsno datano data

1.3yrs

Average Tenure

41yo

Average Age

Experienced Management: NGMD's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Karen Dunlap
Chief Executive Officer3.2yrsCA$142.80k0.069%
CA$ 12.0k
Lin Liang
Executive Chairmanless than a yearno datano data
Erik Emerson
Member of Advisory Board2.2yrsno datano data
Arvind Rai
Directorless than a yearno datano data
John Leombruno
Independent Director3.2yrsno data2.43%
CA$ 422.9k
Greg Gironda
Member of Advisory Board2.3yrsno datano data
Philip Cortese
Independent Director1.9yrsno datano data
Louise Cresswell
Directorless than a yearno datano data
Kwun Liu
Directorless than a yearno datano data

1.9yrs

Average Tenure

54yo

Average Age

Experienced Board: NGMD's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 16:47
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NuGen Medical Devices Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution